Immunotherapy is a gene-editing cell treatment that uses a cancer patient's own immune system to fight cancer cells. And scientists say it has an over 90% success rate. Lead researcher Stanley Riddell at the Fred Hutchinson Cancer Research Center says, "We are at the precipice of a revolution."